Anti‐TNF‐α therapy alters the gut microbiota in proteoglycan‐induced ankylosing spondylitis in mice

Anti‐TNF‐α therapy alters the gut microbiota in proteoglycan‐induced ankylosing spondylitis in mice

Abstract Ankylosing spondylitis is a chronic, progressive disease, and its treatment is relevant to the gut microbiota. Anti‐tumor necrosis factor‐alpha (anti‐TNF‐α) therapy alters the gut microbiota in many diseases, including inflammatory bowel disease. However, little is known about the effect of...

Full description

Bibliographic Details
Main Authors: Bin Liu, Lianjun Yang, Zhifei Cui, Junchi Zheng, Jincheng Huang, Qinghao Zhao, Zhihai Su, Min Wang, Weicong Zhang, Jinshi Liu, Tingxuan Wang, Qingchu Li, Hai Lu
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:MicrobiologyOpen
Subjects:
16S rDNA high‐throughput sequencing
ankylosing spondylitis
anti‐TNF‐alpha therapy
gut microbiota
proteoglycan‐induced mice
Online Access:https://doi.org/10.1002/mbo3.927

Internet

https://doi.org/10.1002/mbo3.927

Similar Items